Literature DB >> 21490063

β-Catenin is essential for Müllerian duct regression during male sexual differentiation.

Akio Kobayashi1, C Allison Stewart, Ying Wang, Kaoru Fujioka, Nicholas C Thomas, Soazik P Jamin, Richard R Behringer.   

Abstract

During male sexual differentiation, the transforming growth factor-β (TGF-β) signaling molecule anti-Müllerian hormone (AMH; also known as Müllerian inhibiting substance, MIS) is secreted by the fetal testes and induces regression of the Müllerian ducts, the primordia of the female reproductive tract organs. Currently, the molecular identity of downstream events regulated by the AMH signaling pathway remains unclear. We found that male-specific Wnt4 expression in mouse Müllerian duct mesenchyme depends upon AMH signaling, implicating the WNT pathway as a downstream mediator of Müllerian duct regression. Inactivation of β-catenin, a mediator of the canonical WNT pathway, did not affect AMH signaling activation in the Müllerian duct mesenchyme, but did block Müllerian duct regression. These data suggest that β-catenin mediates AMH signaling for Müllerian duct regression during male sexual differentiation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21490063      PMCID: PMC3082302          DOI: 10.1242/dev.056143

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  62 in total

Review 1.  Hormones in male sexual development.

Authors:  S Nef; L F Parada
Journal:  Genes Dev       Date:  2000-12-15       Impact factor: 11.361

2.  Epiblast-restricted Cre expression in MORE mice: a tool to distinguish embryonic vs. extra-embryonic gene function.

Authors:  M D Tallquist; P Soriano
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

3.  Widespread recombinase expression using FLPeR (flipper) mice.

Authors:  F W Farley; P Soriano; L S Steffen; S M Dymecki
Journal:  Genesis       Date:  2000 Nov-Dec       Impact factor: 2.487

4.  High specificity of Müllerian-inhibiting substance signaling in vivo.

Authors:  Y Mishina; D J Whitworth; C Racine; R R Behringer
Journal:  Endocrinology       Date:  1999-05       Impact factor: 4.736

5.  Distinct and sequential tissue-specific activities of the LIM-class homeobox gene Lim1 for tubular morphogenesis during kidney development.

Authors:  Akio Kobayashi; Kin-Ming Kwan; Thomas J Carroll; Andrew P McMahon; Cathy L Mendelsohn; Richard R Behringer
Journal:  Development       Date:  2005-06       Impact factor: 6.868

Review 6.  Persistence of Müllerian derivatives in males.

Authors:  C Belville; N Josso; J Y Picard
Journal:  Am J Med Genet       Date:  1999-12-29

Review 7.  Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications.

Authors:  J Teixeira; S Maheswaran; P K Donahoe
Journal:  Endocr Rev       Date:  2001-10       Impact factor: 19.871

8.  Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development.

Authors:  V Brault; R Moore; S Kutsch; M Ishibashi; D H Rowitch; A P McMahon; L Sommer; O Boussadia; R Kemler
Journal:  Development       Date:  2001-04       Impact factor: 6.868

9.  Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development.

Authors:  Lori M Roberts; Jenny A Visser; Holly A Ingraham
Journal:  Development       Date:  2002-03       Impact factor: 6.868

10.  Molecular mechanisms of hormone-mediated Müllerian duct regression: involvement of beta-catenin.

Authors:  S Allard; P Adin; L Gouédard; N di Clemente; N Josso; M C Orgebin-Crist; J Y Picard; F Xavier
Journal:  Development       Date:  2000-08       Impact factor: 6.868

View more
  35 in total

Review 1.  A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice.

Authors:  Kevin A Maupin; Casey J Droscha; Bart O Williams
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

2.  Adenomatous polyposis coli (APC) is essential for maintaining the integrity of the seminiferous epithelium.

Authors:  Pradeep S Tanwar; Lihua Zhang; Jose M Teixeira
Journal:  Mol Endocrinol       Date:  2011-08-04

Review 3.  Non-apoptotic cell death in animal development.

Authors:  Lena M Kutscher; Shai Shaham
Journal:  Cell Death Differ       Date:  2017-02-17       Impact factor: 15.828

Review 4.  Development of the human female reproductive tract.

Authors:  Gerald R Cunha; Stanley J Robboy; Takeshi Kurita; Dylan Isaacson; Joel Shen; Mei Cao; Laurence S Baskin
Journal:  Differentiation       Date:  2018-09-06       Impact factor: 3.880

5.  Osterix functions downstream of anti-Müllerian hormone signaling to regulate Müllerian duct regression.

Authors:  Rachel D Mullen; Ying Wang; Bin Liu; Emma L Moore; Richard R Behringer
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-30       Impact factor: 11.205

Review 6.  An update on stem cell therapy for Asherman syndrome.

Authors:  Ariel Benor; Steven Gay; Alan DeCherney
Journal:  J Assist Reprod Genet       Date:  2020-05-22       Impact factor: 3.412

7.  CTNNB1 in mesenchyme regulates epithelial cell differentiation during Müllerian duct and postnatal uterine development.

Authors:  C Allison Stewart; Ying Wang; Margarita Bonilla-Claudio; James F Martin; Gabriel Gonzalez; Makoto M Taketo; Richard R Behringer
Journal:  Mol Endocrinol       Date:  2013-07-31

8.  Induction of WNT inhibitory factor 1 expression by Müllerian inhibiting substance/antiMullerian hormone in the Müllerian duct mesenchyme is linked to Müllerian duct regression.

Authors:  Joo Hyun Park; Yoshihiro Tanaka; Nelson A Arango; Lihua Zhang; L Andrew Benedict; Mi In Roh; Patricia K Donahoe; Jose M Teixeira
Journal:  Dev Biol       Date:  2013-12-19       Impact factor: 3.582

Review 9.  Molecular genetics of Müllerian duct formation, regression and differentiation.

Authors:  Rachel D Mullen; Richard R Behringer
Journal:  Sex Dev       Date:  2014-07-12       Impact factor: 1.824

10.  Wnt4/β-catenin signaling in medullary kidney myofibroblasts.

Authors:  Derek P DiRocco; Akio Kobayashi; Makoto M Taketo; Andrew P McMahon; Benjamin D Humphreys
Journal:  J Am Soc Nephrol       Date:  2013-06-13       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.